Article Text

other Versions

PDF
Neonatal total IgE and respiratory tract infections in children with intrauterine smoke exposure
  1. Jopje Ruskamp1,
  2. Henriette Smit2,
  3. Maroeska Rovers3,
  4. Maarten Hoekstra1,
  5. Anne Schilder4,
  6. Bert Brunekreef3,5,
  7. Alet Wijga2,
  8. Marjan Kerkhof6,
  9. Johan de Jongste7 and
  10. Elisabeth Sanders8
    1. Correspondence to Jopje Ruskamp, Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands; j.ruskamp{at}umcutrecht.nl

    Abstract

    Background Exposure to environmental tobacco smoke (ETS) is known to increase the risk of respiratory tract infections (RTI). Some children, however, may be more susceptible to the harmful effects of ETS than others. We examined whether early atopic status (defined by elevated neonatal total IgE (tIgE) or symptoms of atopic dermatitis) modified the association between ETS exposure and RTI.

    Methods The data of 2863 children from the Prevention and Incidence of Asthma and Mite Allergy birth cohort were collected to the age of 4 years. Neonatal tIgE was collected from a subset of 914 children, and clinical information by yearly parental questionnaires. The effect of pre- and/or postnatal ETS exposure, early atopic status and interaction between these factors was studied for various RTI.

    Results Children with elevated tIgE or atopic dermatitis and prenatal ETS exposure have a strongly increased risk of frequent RTI (aOR 6.18 (95% CI 1.45 to 26.34) and 5.69 (2.01 to 16.04), respectively; interaction p=0.006 and p=0.14, respectively) compared to non-atopic children without prenatal ETS exposure. Similar results were seen for lower RTI and otitis. This effect was less evident for postnatal ETS.

    Conclusion Early atopic status enhances the risk of RTI in children with prenatal ETS exposure. This suggests that host factors modify the association between ETS and RTI.

    Statistics from Altmetric.com

    Footnotes

    • The Prevention and Incidence of Asthma and Mite Allergy study is supported by the Netherlands Organization for Health Research and Development (ZON-MW), the Netherlands Asthma Fund, the National Institute of Public Health and the Environment, and the Ministry of Housing, Urban Planning, and the Environment. Jopje Ruskamp is supported by the Wilhelmina Research Fund of the UMC Utrecht.

    • None.

    • The study was approved by the Institutional Review Board.

    • Not commissioned; externally peer reviewed.

    • Parental consent obtained.

      • Accepted December 22, 2009.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.